Session » Genetics, Genomics and Proteomics Poster

Date: Sunday, November 13, 2022

Time: 1:00PM-3:00PM

Meeting: ACR Convergence 2022

1:00PM-3:00PM: Abstract Number: 1149

A Novel Mitochondrial Variant as a Predictor for the Rapid Progressive Knee Osteoarthritis Phenotype: Development of a Predictive Model and Functional Studies

1:00PM-3:00PM: Abstract Number: 1133

Ancestry, ACKR1, and Leucopenia in Patients with Systemic Lupus Erythematosus

1:00PM-3:00PM: Abstract Number: 1124

CD4+ Cytotoxic T Lymphocytes (CTL) Are Present in Sjögren’s Disease Minor Salivary Glands and Associate with Markers of Epithelial Cell Damage near Infiltrates

1:00PM-3:00PM: Abstract Number: 1144

Circulating miRNAs and Difficult-To-Treat Rheumatoid Arthritis: The Screening Study

1:00PM-3:00PM: Abstract Number: 1141

Consequences of SLE Heterogeneity on the Epigenome and the Drivers Behind

1:00PM-3:00PM: Abstract Number: 1143

Epigenome-wide Analysis of Osteoarthritis in the Multicenter Osteoarthritis Study

1:00PM-3:00PM: Abstract Number: 1123

Excess of Rare Deleterious Variants Within JAK-STAT Pathway – Related Genes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease

1:00PM-3:00PM: Abstract Number: 1126

Functional NOTCH4 Variants Increase Notch Signaling and Susceptibility for Systemic Sclerosis

1:00PM-3:00PM: Abstract Number: 1146

Genetic Interactions Between T-Cell Receptor Polymorphisms and HLA Amino Acids Contribute to the Risk of Rheumatoid Arthritis

1:00PM-3:00PM: Abstract Number: 1134

Genome-wide Association Study Identifies Novel Loci for Leukopenia Among TPMT and NUDT15 Normal Metabolizers Taking Azathioprine

1:00PM-3:00PM: Abstract Number: 1125

Genomics of JAK-STAT Signaling in Venous Thromboembolism

1:00PM-3:00PM: Abstract Number: 1148

GWAS Identified New Genes in Synovial Fibroblasts Linked to Early Remission in RA

1:00PM-3:00PM: Abstract Number: 1130

Identification of Novel Molecular Signatures Associated with the Therapeutic Response to DMARDs and TNFi Therapies in Rheumatoid Arthritis Patients Through High Throughput Proteomics

1:00PM-3:00PM: Abstract Number: 1129

Integrated High-throughput Proteomics and Machine Learning Analysis in Systemic Lupus Erythematosus Patients Identify Distinctive Clinical Profiles and Novel Biomarkers Related to Cardiovascular Risk and Lupus Nephropathy

1:00PM-3:00PM: Abstract Number: 1131

Integrating Genome and Transcriptome-Wide Associations with Real-World Data to Assess Risk for Leukopenia in Patients Taking Azathioprine

1:00PM-3:00PM: Abstract Number: 1132

Interaction of LOC100507053, ADH1B, and ADH1C with Alcohol Consumption for Elevated Serum Urate Levels and Gout in People of European Ethnicity

1:00PM-3:00PM: Abstract Number: 1121

Intricate Roles of Low Gene Copy Numbers for Complement C4, C4A Deficiency and HLA-DRB1*03 as Genetic Risk Factors for Myositis, Its Subgroups and Autoantibodies

1:00PM-3:00PM: Abstract Number: 1119

Investigating Macrophage Heterogeneity in the Esophagus and Lungs of SSc Patients

1:00PM-3:00PM: Abstract Number: 1137

MHC Class I Polypeptide-Related Sequence a Variant Predicts Real-World Response to Anti-TNF Therapy

1:00PM-3:00PM: Abstract Number: 1139

Molecular Pathways Identified from Risk Alleles Identify Mechanistic Differences in Systemic Lupus Erythematosus Patients of East Asian and European Ancestry

1:00PM-3:00PM: Abstract Number: 1118

Monocyte Transcriptomic Analysis Uncovers Heterogeneous Gene Expression Profiles in Systemic Lupus Erythematous (SLE) with and Without Subclinical Atherosclerosis

1:00PM-3:00PM: Abstract Number: 1122

Short Peripheral Blood Leukocyte Telomere Length in Rheumatoid Arthritis – Interstitial Lung Disease

1:00PM-3:00PM: Abstract Number: 1136

Stratification of Systemic Lupus Erythematosus (SLE) Patients Based on the Molecular Patterns of Mouse Models

1:00PM-3:00PM: Abstract Number: 1128

The Causal Association Between Osteoarthritis and Common Comorbidities: A Mendelian Randomisation Study

1:00PM-3:00PM: Abstract Number: 1142

The Lupus Risk Allele Associated Xq28 Haplotype Identifies the Molecular Endotype of a Cohort of European SLE Patients with Enhanced IRAK1 Signaling

1:00PM-3:00PM: Abstract Number: 1145

The Prostate Plays a Role in Serum Urate Levels and the Risk of Gout in Men

1:00PM-3:00PM: Abstract Number: 1120

Transcriptome-Wide Association Study of Sjögren’s Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues

1:00PM-3:00PM: Abstract Number: 1147

Transcriptomic Changes Induced by Tocilizumab in Ex-Vivo PBMCs from Patients with GCA in Remission. Predictors of Response

1:00PM-3:00PM: Abstract Number: 1127

Unsupervised Clustering Analysis of the Serum Proteome Identifies Systemic Sclerosis Patients with Distinctive Clinical Features

1:00PM-3:00PM: Abstract Number: 1135

Urine Proteomics Implicate Complement C3 and Factor I in Lupus Nephritis Patients with Interstitial Fibrosis and Tubular Atrophy

1:00PM-3:00PM: Abstract Number: 1138

Whole-Blood DNA Methylation Analysis Reveals Respiratory Environmental Traits Involved in COVID-19 Severity Following SARS-CoV-2 Infection and Common Molecular Signatures with Autoimmune Diseases

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].